Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 17 | 2025 | 1125 | 1.510 |
Why?
|
| Heart Ventricles | 7 | 2023 | 783 | 1.060 |
Why?
|
| Calcinosis | 3 | 2012 | 191 | 0.820 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 2 | 2012 | 44 | 0.710 |
Why?
|
| Emergency Medicine | 1 | 2022 | 163 | 0.640 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 196 | 0.610 |
Why?
|
| Heart-Assist Devices | 5 | 2024 | 1081 | 0.600 |
Why?
|
| Echocardiography, Transesophageal | 8 | 2013 | 257 | 0.600 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 37 | 0.600 |
Why?
|
| Heart Failure | 8 | 2024 | 2401 | 0.580 |
Why?
|
| Mitral Valve | 5 | 2012 | 268 | 0.560 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2013 | 157 | 0.530 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 157 | 0.510 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2014 | 21 | 0.430 |
Why?
|
| Systole | 4 | 2023 | 205 | 0.420 |
Why?
|
| Cardiology | 5 | 2024 | 498 | 0.410 |
Why?
|
| Incidental Findings | 2 | 2012 | 130 | 0.410 |
Why?
|
| Ventricular Function, Left | 5 | 2024 | 546 | 0.400 |
Why?
|
| Thrombosis | 3 | 2012 | 524 | 0.390 |
Why?
|
| Sinus of Valsalva | 1 | 2013 | 35 | 0.390 |
Why?
|
| Societies, Medical | 4 | 2025 | 779 | 0.390 |
Why?
|
| Pericardium | 1 | 2013 | 91 | 0.370 |
Why?
|
| Ablation Techniques | 1 | 2012 | 31 | 0.360 |
Why?
|
| Aortic Rupture | 1 | 2013 | 119 | 0.360 |
Why?
|
| American Heart Association | 4 | 2022 | 309 | 0.360 |
Why?
|
| Ethanol | 1 | 2012 | 162 | 0.340 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2020 | 458 | 0.330 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2013 | 114 | 0.310 |
Why?
|
| Quality Assurance, Health Care | 4 | 2013 | 215 | 0.310 |
Why?
|
| Diagnostic Imaging | 4 | 2014 | 313 | 0.310 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 341 | 0.300 |
Why?
|
| Fluorocarbons | 2 | 2008 | 58 | 0.280 |
Why?
|
| Methemoglobinemia | 1 | 2008 | 9 | 0.280 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 6 | 0.280 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 39 | 0.270 |
Why?
|
| Cardiac Tamponade | 1 | 2008 | 38 | 0.270 |
Why?
|
| Palliative Care | 1 | 2012 | 456 | 0.270 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 61 | 0.270 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 90 | 0.270 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2008 | 64 | 0.270 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 72 | 0.270 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2008 | 79 | 0.260 |
Why?
|
| Cor Triatriatum | 1 | 2007 | 10 | 0.260 |
Why?
|
| Hematoma | 1 | 2008 | 92 | 0.260 |
Why?
|
| Humans | 44 | 2025 | 132064 | 0.250 |
Why?
|
| Prosthesis Implantation | 2 | 2024 | 153 | 0.250 |
Why?
|
| Contrast Media | 2 | 2012 | 507 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 221 | 0.240 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 133 | 0.220 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 508 | 0.220 |
Why?
|
| Albumins | 1 | 2005 | 95 | 0.220 |
Why?
|
| Vascular Resistance | 2 | 2024 | 195 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1173 | 0.210 |
Why?
|
| Heart Septum | 1 | 2003 | 55 | 0.210 |
Why?
|
| Heart Neoplasms | 1 | 2005 | 104 | 0.210 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 109 | 0.210 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 119 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2020 | 482 | 0.200 |
Why?
|
| Chest Pain | 2 | 2022 | 128 | 0.190 |
Why?
|
| Heart Valve Prosthesis | 3 | 2004 | 328 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2012 | 374 | 0.190 |
Why?
|
| Sarcoma | 1 | 2005 | 207 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 185 | 0.190 |
Why?
|
| Advisory Committees | 2 | 2013 | 151 | 0.190 |
Why?
|
| Predictive Value of Tests | 5 | 2022 | 2311 | 0.190 |
Why?
|
| Ultrasonography | 3 | 2022 | 984 | 0.180 |
Why?
|
| Male | 21 | 2024 | 64938 | 0.180 |
Why?
|
| Cardiovascular Diseases | 5 | 2013 | 2089 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2002 | 175 | 0.170 |
Why?
|
| Adult | 15 | 2025 | 31571 | 0.170 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 459 | 0.170 |
Why?
|
| Thrombolytic Therapy | 2 | 2004 | 215 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 1300 | 0.170 |
Why?
|
| Echocardiography, Doppler | 3 | 2010 | 172 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2013 | 393 | 0.160 |
Why?
|
| Exercise Test | 1 | 2001 | 257 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 178 | 0.150 |
Why?
|
| Treatment Outcome | 7 | 2024 | 13000 | 0.150 |
Why?
|
| United States | 12 | 2025 | 11660 | 0.140 |
Why?
|
| Female | 18 | 2024 | 70664 | 0.140 |
Why?
|
| Diastole | 1 | 1999 | 181 | 0.140 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 21 | 0.140 |
Why?
|
| Echocardiography, Stress | 2 | 2008 | 18 | 0.140 |
Why?
|
| Heart | 1 | 2022 | 689 | 0.140 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1998 | 38 | 0.140 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 244 | 0.130 |
Why?
|
| Nebivolol | 1 | 2016 | 4 | 0.130 |
Why?
|
| Vagus Nerve | 1 | 2017 | 48 | 0.130 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2016 | 13 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 1998 | 163 | 0.130 |
Why?
|
| Metoprolol | 1 | 2016 | 19 | 0.130 |
Why?
|
| Heart Diseases | 3 | 2010 | 511 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2013 | 857 | 0.130 |
Why?
|
| Middle Aged | 12 | 2024 | 28993 | 0.130 |
Why?
|
| Microspheres | 2 | 2008 | 73 | 0.130 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 377 | 0.130 |
Why?
|
| Defibrillators, Implantable | 2 | 2013 | 204 | 0.130 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2013 | 20 | 0.120 |
Why?
|
| Heart Conduction System | 1 | 2017 | 156 | 0.120 |
Why?
|
| Electrocardiography | 3 | 2014 | 995 | 0.120 |
Why?
|
| Risk Assessment | 6 | 2024 | 3731 | 0.120 |
Why?
|
| Botulinum Toxins | 1 | 2017 | 122 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 211 | 0.110 |
Why?
|
| Biomedical Technology | 1 | 2013 | 36 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 33 | 0.100 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2013 | 56 | 0.100 |
Why?
|
| Anticoagulants | 2 | 2012 | 607 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2014 | 487 | 0.090 |
Why?
|
| Heart Rate | 1 | 2014 | 584 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 5412 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 87 | 0.090 |
Why?
|
| Laboratories, Hospital | 1 | 2011 | 24 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1957 | 0.080 |
Why?
|
| Risk Factors | 4 | 2024 | 10938 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 1351 | 0.080 |
Why?
|
| Aspirin | 1 | 2012 | 220 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17389 | 0.080 |
Why?
|
| Aged | 8 | 2024 | 21426 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 737 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2010 | 666 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3842 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1177 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 11 | 0.070 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Heart Transplantation | 2 | 2024 | 883 | 0.070 |
Why?
|
| Cyanosis | 1 | 2008 | 43 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2911 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 373 | 0.060 |
Why?
|
| Oximetry | 1 | 2008 | 178 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 171 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 189 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 247 | 0.060 |
Why?
|
| Coronary Disease | 3 | 2008 | 685 | 0.060 |
Why?
|
| Anesthetics, Dissociative | 1 | 2004 | 18 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2024 | 28 | 0.050 |
Why?
|
| Radiography | 1 | 2006 | 819 | 0.050 |
Why?
|
| Death, Sudden | 1 | 2003 | 47 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 439 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 7107 | 0.050 |
Why?
|
| Utilization Review | 2 | 2013 | 40 | 0.050 |
Why?
|
| Decision Making | 3 | 2014 | 700 | 0.050 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2002 | 33 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 223 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2024 | 232 | 0.050 |
Why?
|
| Health Services Research | 2 | 2013 | 186 | 0.040 |
Why?
|
| Organ Size | 1 | 2022 | 446 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2007 | 767 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 204 | 0.040 |
Why?
|
| Ketamine | 1 | 2004 | 226 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1294 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 1230 | 0.040 |
Why?
|
| Dobutamine | 1 | 1999 | 56 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 406 | 0.040 |
Why?
|
| Patient Safety | 2 | 2014 | 439 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 2227 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2020 | 425 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 229 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1718 | 0.030 |
Why?
|
| Warfarin | 1 | 1998 | 127 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 121 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 547 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 3089 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 167 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 125 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 1995 | 25 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 421 | 0.030 |
Why?
|
| Prognosis | 3 | 1999 | 5010 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6444 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 536 | 0.030 |
Why?
|
| Mutation | 1 | 2008 | 6226 | 0.030 |
Why?
|
| Hypotension | 1 | 1995 | 185 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1671 | 0.030 |
Why?
|
| Coronary Occlusion | 1 | 2013 | 32 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2013 | 146 | 0.030 |
Why?
|
| Vascular Calcification | 1 | 2013 | 71 | 0.020 |
Why?
|
| Cattle | 2 | 2004 | 569 | 0.020 |
Why?
|
| Mass Screening | 2 | 2008 | 828 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 652 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 576 | 0.020 |
Why?
|
| Animals | 4 | 2017 | 34804 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2010 | 136 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 20542 | 0.020 |
Why?
|
| Myocardium | 1 | 2014 | 906 | 0.020 |
Why?
|
| Regional Health Planning | 1 | 2008 | 6 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 462 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 77 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1606 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 858 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2008 | 105 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 133 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 893 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 4684 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2008 | 367 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 732 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 37 | 0.010 |
Why?
|
| Reference Standards | 1 | 2004 | 242 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2007 | 408 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2164 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2004 | 663 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 1596 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3137 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1995 | 523 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 618 | 0.010 |
Why?
|
| Survival Rate | 1 | 1995 | 2193 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1995 | 6570 | 0.000 |
Why?
|